Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the beginning of 2018. Several of the CTS client forms specify list the Medical Director in the header and these forms will be updated on March 5, 2018. Check out the Communication page for a complete list of forms or by clicking the link below: Communications
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...